Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
Filed with ASX · · 2 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix and ANMI Expand PSMA Imaging Partnership
- Cyclotek Manufacturing Partnership for Kidney Cancer Imaging
- Strategic Collaboration Agreement with GenesisCare
- Telix completes acquisition of Atlab Pharma
- TLX receives ethics approval to commence Glioblastoma Study
Later from Telix Pharmaceuticals
- Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial
- Appendix 4C - September Quarter
- Telix Acquires Advanced Nuclear Medicine Ingredients SA
- ANMI Transaction - Market Briefing
- Nihon Medi-Physics Collaboration on Actinium Renal Cancer
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals